GET THE APP

Genetic and Metabolic Conditions are Diagnosed
..

Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

Opinion - (2023) Volume 14, Issue 1

Genetic and Metabolic Conditions are Diagnosed

Carlotta Sacerdote*
*Correspondence: Carlotta Sacerdote, Department of Medical Sciences, University of Turin, 10126 Turin, Italy, Email:
Department of Medical Sciences, University of Turin, 10126 Turin, Italy

Received: 02-Jan-2023, Manuscript No. jmbd-23-91942; Editor assigned: 04-Jan-2023, Pre QC No. P-91942; Reviewed: 18-Jan-2023, QC No. Q-91942; Revised: 23-Jan-2023, Manuscript No. R-91942; Published: 30-Jan-2023 , DOI: 10.37421/2155-9929.2023.14.564
Citation: Sacerdote, Carlotta. â??Genetic and Metabolic Conditions are Diagnosed." J Mol Biomark Diagn 14 (2023): 564.
Copyright: © 2023 Sacerdote C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Genetic diagnosis is the process of determining the genetic makeup of an individual through a variety of techniques. The genetic information of an individual is encoded in their DNA, which is present in all of their cells. Genetic diagnosis is important in the diagnosis and management of genetic diseases, and is also used in many areas of research. In this article, we will explore the different types of genetic diagnosis, the techniques used, and their applications. There are two main types of genetic diagnosis. Germline genetic diagnosis looks at the DNA of an individual's reproductive cells, which are passed down from parent to child. Somatic genetic diagnosis, on the other hand, looks at the DNA of an individual's non-reproductive cells, such as skin or blood cells. Somatic mutations are not passed on to offspring. Germline genetic diagnosis is used to identify inherited genetic disorders, such as cystic fibrosis, Huntington's disease, and sickle cell anemia. These disorders are caused by mutations in a specific gene or set of genes, and can be passed down from one generation to the next. Germline genetic diagnosis is also used in assisted reproductive technologies, such as in vitro fertilization, to screen embryos for genetic disorders before implantation.

Description

PCR is a technique used to amplify a specific region of DNA, allowing for its detection and analysis. PCR can be used to identify specific genetic mutations, such as those associated with cystic fibrosis or sickle cell anemia. DNA sequencing is the process of determining the order of nucleotides in a DNA molecule. There are several methods of DNA sequencing, including Sanger sequencing and next-generation sequencing (NGS). DNA sequencing is used to identify genetic mutations and can be used to diagnose a wide range of genetic disorders. FISH is a technique used to detect the presence or absence of specific genes or chromosomal abnormalities. FISH is often used in the diagnosis of cancer and can help identify specific chromosomal abnormalities associated with certain types of cancer. Microarray analysis is a technique used to analyze the expression of thousands of genes simultaneously. This technique is often used in cancer research to identify specific genes that are overexpressed or underexpressed in tumors [1].

Genetic diagnosis has a wide range of applications, from identifying genetic disorders to guiding cancer treatment decisions. Some of the most common applications of genetic diagnosis include. Genetic diagnosis is an important tool in the diagnosis of inherited genetic disorders, such as cystic fibrosis, Huntington's disease, and sickle cell anemia. Early diagnosis can help individuals and their families better manage these disorders and plan for the future. Carrier screening is the process of testing individuals for genetic mutations that they may pass down to their offspring. Carrier screening is often recommended for individuals who are planning to start a family, particularly if there is a family history of genetic disorders. Prenatal diagnosis involves testing the DNA of a developing fetus to determine if it has any genetic [2-5].

Conclusion

Genetic diagnosis is an important tool in the diagnosis of inherited genetic disorders, such as cystic fibrosis, Huntington's disease, and sickle cell anaemia. Early diagnosis can help individuals and their families better manage these disorders and plan for the future. Carrier screening is the process of testing individuals for genetic mutations that they may pass down to their offspring. Carrier screening is often recommended for individuals who are planning to start a family, particularly if there is a family history of genetic disorders. Prenatal diagnosis involves testing the DNA of a developing fetus to determine if it has any genetic. Our understanding of the genetic basis of many diseases is still limited, and genetic diagnosis may not always provide a clear answer. Genetic testing can produce false positive or false negative results, leading to unnecessary anxiety or missed diagnoses. Genetic diagnosis can have a significant psychological impact on individuals and families, particularly when a diagnosis carries a significant risk of developing a severe disease. Genetic diagnosis raises ethical questions related to issues such as informed consent, privacy, and discrimination.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

  1. Chen, Sining and Giovanni Parmigiani. "Meta-analysis of BRCA1 and BRCA2 penetrance." Am J Clin Oncol 25 (2007): 1329.
  2. Google Scholar, Crossref, Indexed at

  3. Sterne, Jonathan AC, Alex J. Sutton, John PA Ioannidis and Norma Terrin, et al. "Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials." Bmj 343 (2011).
  4. Google Scholar, Crossref, Indexed at

  5. Guo, Li-Juan and Qing-Yun Zhang. "Decreased serum miR-181a is a potential new tool for breast cancer screening." Int J Mol Med 30 (2012): 680-686.
  6. Google Scholar, Crossref, Indexed at

  7. Zeng, Rui-chao, Wei Zhang, Xing-qiang Yan and Zhi-qiang Ye, et al. "Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer." Med Oncol 30 (2013): 1-8.
  8. Google Scholar, Crossref, Indexed at

  9. Zhao, Fu-long, Yue-chao Dou, Xue-fei Wang and Da-cheng Han, et al. "Serum microRNA-195 is down-regulated in breast cancer: A potential marker for the diagnosis of breast cancer." Mol Biol Rep 41 (2014): 5913-5922.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 2054

Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward